More research into digestive disease
Carle is increasing its research efforts in hopes of finding effective treatments or even cures for gastrointestinal conditions such as Crohn’s disease and ulcerative colitis.
After 30-years in private practice, Glenn L. Gordon, MD, FACP, FACG, AGAF, FASGE, FACIP, recently joined Carle and is opening close to 40 clinical trials to offer patients in this region an opportunity to treat Inflammatory Bowel Disease and other intestinal problems with newer and more advanced therapy.
“I knew since the age of 10 that I wanted to become a physician and my interest leaned towards gastroenterology as I had a family member who was afflicted with Crohn’s Disease,” Dr. Gordon said. “Bowel diseases and conditions are serious, can be painful and severely impact a person’s quality of life. Ultimately my goal is to put ourselves out of business, to find a cure for Inflammatory Bowel Disease in particular.”
Specifically, Dr. Gordon is conducting over 20 clinical trials that are investigating various medicines to treat Crohn’s disease and ulcerative colitis. “We have seen exponential growth in terms of agents and products that can alter our thinking in immunology,” Dr. Gordon said. “Thanks to clinical trials, we can target medications very specifically to the GI tract, so as to limit potential side effects.”
Dr. Gordon says people who participate in these clinical trials help find new ways to treat intestinal problems. “By participating, our patients can have a more active role in their own healthcare, have more treatment options, gain access to new research treatments before they become widely available and help themselves and others by contributing to medical research going forward,” Dr. Gordon commented. “We’re going to be providing new opportunities and enhance local care for Carle patients.”
“Carle has a long history of digestive disease research, and with the arrival of Dr. Gordon, we will be able to expand our research capabilities into different areas that Carle previously didn’t investigate. We are excited that Dr. Gordon’s research will focus on medicines to treat and help patients,” said Eugene Greenberg, MD, gastroenterologist at Carle. “Dr. Gordon is a premier researcher and we are glad to have him at Carle.”
Carle Digestive Health Research is currently enrolling for clinical trials. For more information about digestive health studies call (217) 326-0080.
# # #